Minerva Neurosciences (NERV) Other financing activities (2015 - 2026)
Minerva Neurosciences' (NERV) quarterly Other financing activities came in at $1.2 million in Q1 2026, down 98.0% on a QoQ basis from $60.0 million in Q1 2021.
Powered by 
Analysis
Minerva Neurosciences (NERV) Other financing activities (2015 - 2026) Analysis & Trends
Minerva Neurosciences (NERV) has 9 years of Other financing activities data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY) and the FY2025 annual result came in at $80.0 million, changed N/A from the prior year.
- Other financing activities eased to $1.2 million in Q1 2026, from $60.0 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.2 million in Q1 2026 to a low of $1.2 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Minerva Neurosciences | 207.37 Mn | 207.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.50 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2021 | 60.00 Mn |
| Sep 30, 2020 | 7.37 Mn |
| Jun 30, 2020 | 4.38 Mn |
| Mar 31, 2020 | 797,629.00 |
| Dec 31, 2019 | -1.00 |
| Mar 31, 2019 | 525,000.00 |
| Dec 31, 2018 | 165,105.00 |
| Jun 30, 2017 | -43,167.00 |
| Mar 31, 2017 | 9.40 Mn |
| Dec 31, 2016 | 1.17 Mn |
| Jun 30, 2016 | 21.22 Mn |
| Mar 31, 2016 | 17.54 Mn |
| Jun 30, 2015 | -1.00 |
| Mar 31, 2015 | 31.00 Mn |